Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07664358 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fibrinogen-to-Albumin Ratio as a Predictor of Acute Respiratory Distress Syndrome in Traumatic Brain Injury

Study acronym: FARDS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Oct 1, 2026 → Nov 1, 2026
See other at-risk trials from Tanta University

Record History

  1. Primary completion pushed from Oct 1, 2026 to Nov 1, 2026 Completion pushed from Jan 1, 2027 to Feb 1, 2027 · Eligibility criteria expanded, about 13 words · Secondary endpoints: details revised at 4 of 7 entries Show 3 more changesShow less
    • Completion pushed from Jan 1, 2027 to Feb 1, 2027
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 4 of 7 entries
  2. Recruitment opened Primary completion moved earlier from Dec 1, 2026 to Oct 1, 2026 · Completion date: Dec 30, 2026 to Jan 1, 2027 · Secondary endpoints: 4 to 7 · 1 morev2 Show 4 more changesShow less
    • Primary completion moved earlier from Dec 1, 2026 to Oct 1, 2026
    • Completion date: Dec 30, 2026 to Jan 1, 2027
    • Secondary endpoints: 4 to 7
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
this study aims to assess the ability of fibrinogen-to-albumin ratio to predict the development of Acute respiratory distress syndrome in traumatic brain injury patients.
Trial Details
NCT Number NCT07664358
Lead Sponsor Tanta University
Conditions Fibrinogen, Albumin, ARDS, TBI (Traumatic Brain Injury)
Enrollment 350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov